# Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson’s Disease and Related Genotoxic Endpoints

**Authors:** Mohammad Shoeb, Breanna Alman, Harpriya Kaur, Moon Han, Fahim Atif, William Wu Kim, Siddhi Desai, Patricia Ruiz, Gregory M. Zarus

PMC · DOI: 10.3390/genes17020236 · Genes · 2026-02-13

## TL;DR

This paper reviews how environmental toxins like metals and pesticides may contribute to Parkinson's disease and related genetic damage.

## Contribution

The paper identifies 29 neurotoxic substances linked to Parkinson’s disease and explores genotoxic endpoints connecting environmental exposure to disease mechanisms.

## Key findings

- 29 substances were identified as neurotoxic and possibly linked to Parkinson’s disease.
- Genotoxic endpoints like oxidative stress and DNA damage are associated with environmental exposures in PD.
- Environmental toxins often co-occur, complicating individual risk assessment for Parkinson’s disease.

## Abstract

Parkinson’s disease (PD) is a complex neurodegenerative disorder influenced by age, genetic predispositions, and environmental exposures, with a growing global incidence. This review aims to summarize findings from ATSDR Toxicological Profiles, EPA Risk Assessments, and other sources of peer-reviewed literature to examine the potential associations between PD and select metals, pesticides, and chlorinated organic compounds. Additionally, it explores using computational toxicology methods to elucidate the interactions between specific chemicals, associated genes, and their possible roles in PD. A total of 29 substances were identified to be neurotoxic with direct or probable association with PD. Risk of disease onset or symptom exacerbation of PD has been linked to exposures to neurodegenerative metals, pesticides, chlorinated organic compounds, and other environmental toxicants, alongside intrinsic factors such as genetic predisposition and aging. Supporting evidence from neurotoxicological studies directly or possibly associated with PD are summarized in referenced toxicological profiles and EPA risk assessments. Genotoxic endpoints evaluated in exposure-induced neurodegeneration including oxidative stress, DNA strand breaks, mitochondrial dysfunction, impaired DNA repair, and telomere alterations may play a critical role in linking environmental exposures to PD pathogenesis. Although these endpoints represent imperative data gaps between environmental and genetic risk factors for PD, isolating individual substances may not be necessary for prevention, as many co-occur at contaminated sites or within certain occupations. Further research is needed to clarify causal relationships between environmental exposure and genotoxic endpoints seen in neurodegenerative processes that can also be seen in PD for consideration in the development of preventive and therapeutic strategies.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}, SLC18A2 (solute carrier family 18 member A2) [NCBI Gene 6571] {aka PKDYS2, SVAT, SVMT, VAT2, VMAT2}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, LRRK2 (leucine rich repeat kinase 2) [NCBI Gene 120892] {aka AURA17, DARDARIN, PARK8, RIPK7, ROCO2}, PON1 (paraoxonase 1) [NCBI Gene 5444] {aka ESA, MVCD5, PON}, PSEN1 (presenilin 1) [NCBI Gene 5663] {aka ACNINV3, AD3, CMD1U, FAD, PS-1, PS1}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, GBA1 (glucosylceramidase beta 1) [NCBI Gene 2629] {aka GBA, GCB, GLUC}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}
- **Diseases:** ADHD (MESH:D001289), slowness of movement (MESH:D020754), toxicity (MESH:D064420), ALS (MESH:D000690), postural instability (MESH:D054972), tremors (MESH:D014202), rigidity (MESH:D009127), MS (MESH:D009103), motor dysfunction (MESH:D000068079), dopaminergic dysfunction (MESH:D009422), cognitive impairment (MESH:D003072), depression (MESH:D003866), dopaminergic neuron degeneration (MESH:D009410), Lewy (MESH:D018827), Parkinson's symptoms (MESH:D010302), cancer (MESH:D009369), Alzheimer's (MESH:D000544), neural damage (MESH:D015441), neurotoxic (MESH:D020258), Lewy bodies (MESH:D020961), neuroinflammation (MESH:D000090862), anxiety (MESH:D001007), dopamine deficit (MESH:C567730), Neurodegeneration (MESH:D019636), injury to (MESH:D014947), inflammatory (MESH:D007249), PD (MESH:D010300), Mitochondrial Dysfunction (MESH:D028361), ASD (MESH:D000067877), sleep disturbance (MESH:D012893), neurological disorders (MESH:D009461)
- **Chemicals:** maneb (MESH:D008344), Glyphosate (MESH:C010974), CTD (-), organophosphate (MESH:D010755), aluminum (MESH:D000535), TCE (MESH:D014241), Hg (MESH:D008628), DDT (MESH:D003634), cadmium (MESH:D002104), dopamine (MESH:D004298), Lead (MESH:D007854), heavy metals (MESH:D019216), ROS (MESH:D017382), Paraquat (MESH:D010269), Mn (MESH:D008345), rotenone (MESH:D012402), MPTP (MESH:D015632), Ni (MESH:D009532), Organochlorines (MESH:D006843), Metals (MESH:D008670), hexachlorobenzene (MESH:D006581), -VOCs (MESH:D055549), 8-oxo-2'-deoxyguanosine (MESH:D000080242), sphingosine-1-phosphate (MESH:C060506)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L55M, R1441C, I2020T, p. V16A, G2019S, A313 G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940381/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940381/full.md

## References

231 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940381/full.md

---
Source: https://tomesphere.com/paper/PMC12940381